BRPI1013548A2 - método de purificação industrial de ficotoxinas biologicamente ativas - Google Patents

método de purificação industrial de ficotoxinas biologicamente ativas

Info

Publication number
BRPI1013548A2
BRPI1013548A2 BRPI1013548A BRPI1013548A BRPI1013548A2 BR PI1013548 A2 BRPI1013548 A2 BR PI1013548A2 BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 A2 BRPI1013548 A2 BR PI1013548A2
Authority
BR
Brazil
Prior art keywords
biologically active
purification method
industrial purification
phytotoxins
active phytotoxins
Prior art date
Application number
BRPI1013548A
Other languages
English (en)
Inventor
Marcelo Santiago Lagos Gonzáles
Original Assignee
Proteus Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Sa filed Critical Proteus Sa
Publication of BRPI1013548A2 publication Critical patent/BRPI1013548A2/pt
Publication of BRPI1013548B1 publication Critical patent/BRPI1013548B1/pt
Publication of BRPI1013548B8 publication Critical patent/BRPI1013548B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
BRPI1013548A 2009-03-24 2010-03-18 método de purificação industrial de ficotoxinas biologicamente ativas BRPI1013548B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2009000723A CL2009000723A1 (es) 2009-03-24 2009-03-24 Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias.
PCT/IB2010/051187 WO2010109386A1 (es) 2009-03-24 2010-03-18 Método de purificación industrial de ficotoxinas biológicamente activas

Publications (3)

Publication Number Publication Date
BRPI1013548A2 true BRPI1013548A2 (pt) 2016-09-20
BRPI1013548B1 BRPI1013548B1 (pt) 2020-06-09
BRPI1013548B8 BRPI1013548B8 (pt) 2021-05-25

Family

ID=42780210

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013548A BRPI1013548B8 (pt) 2009-03-24 2010-03-18 método de purificação industrial de ficotoxinas biologicamente ativas

Country Status (14)

Country Link
EP (1) EP2412714B9 (pt)
JP (1) JP5728774B2 (pt)
KR (1) KR20110130420A (pt)
AR (1) AR075931A1 (pt)
BR (1) BRPI1013548B8 (pt)
CA (1) CA2754154C (pt)
CL (1) CL2009000723A1 (pt)
DK (1) DK2412714T5 (pt)
ES (1) ES2562637T3 (pt)
HR (1) HRP20160079T1 (pt)
HU (1) HUE027480T2 (pt)
MX (1) MX2011010005A (pt)
PE (1) PE20110903A1 (pt)
WO (1) WO2010109386A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
KR102787826B1 (ko) 2013-03-15 2025-03-31 더 칠드런스 메디칼 센터 코포레이션 지속성 국소 마취용 네오삭시톡신 조합 제형
US9902625B2 (en) 2014-09-03 2018-02-27 International Business Machines Corporation Removal of HAB-produced toxins from bodies of water
GB201602576D0 (en) 2016-02-12 2016-03-30 Bergen Teknologioverforing As Process
CN107602580B (zh) * 2017-09-08 2019-06-11 浙江理工大学 一种聚酮类化合物及其制备方法和应用
CN109142595A (zh) * 2018-08-23 2019-01-04 中国水产科学研究院黄海水产研究所 一种麻痹性贝类毒素标准溶液的制备方法
SG11202102830SA (en) * 2018-09-21 2021-04-29 The Cawthron Inst Trust Board Preparative scale conversion of gonyautoxins to neosaxitoxin
GB2587997B (en) * 2018-09-21 2023-05-10 The Cawthron Inst Trust Board A semisynthetic method of preparing neosaxitoxin
US12018034B2 (en) 2018-09-21 2024-06-25 The Cawthron Institute Trust Board Semisynthetic methods of preparing GTX1,4 and neosaxitoxin
CN114657222A (zh) * 2022-04-08 2022-06-24 湖北省水利水电科学研究院 一种从水华束丝藻中提取类菌胞素氨基酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001413A (en) 1973-06-12 1977-01-04 Astra Pharmaceutical Products, Inc. Pharmaceutical local anesthetic composition employing saxitoxin
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
MXPA04004543A (es) * 2001-11-15 2005-03-31 Micro Algae Corp Composiciones farmaceuticas que contienen 3,4-propinoperhidropurinas y sus usos para el bloqueo de la transmision neuronal.
BRPI0510759A (pt) * 2004-05-07 2007-11-20 Phytotox Ltd método de facilitar a cura de um ferimento
DE102006028817A1 (de) * 2006-06-21 2007-12-27 Evonik Degussa Gmbh Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen

Also Published As

Publication number Publication date
KR20110130420A (ko) 2011-12-05
MX2011010005A (es) 2011-10-10
ES2562637T9 (es) 2017-05-30
EP2412714A1 (en) 2012-02-01
DK2412714T3 (en) 2016-02-01
AR075931A1 (es) 2011-05-04
HRP20160079T1 (hr) 2016-04-08
BRPI1013548B1 (pt) 2020-06-09
CA2754154C (en) 2013-12-17
WO2010109386A1 (es) 2010-09-30
JP5728774B2 (ja) 2015-06-03
EP2412714A4 (en) 2012-10-10
DK2412714T5 (en) 2017-02-27
CA2754154A1 (en) 2010-09-30
ES2562637T3 (es) 2016-03-07
JP2012521408A (ja) 2012-09-13
BRPI1013548B8 (pt) 2021-05-25
EP2412714B1 (en) 2015-11-11
EP2412714B9 (en) 2016-11-23
PE20110903A1 (es) 2012-01-19
HUE027480T2 (en) 2016-09-28
CL2009000723A1 (es) 2009-06-19

Similar Documents

Publication Publication Date Title
BRPI1009447A2 (pt) métodos de purificação de proteínas imunofarmacêuticas modulares pequenas
EP2485698A4 (en) WHEELCHAIR SUSPENSION
PL2601979T3 (pl) Sposób sterylizacji
EP2276795A4 (en) Processing biomass
EP2226331A4 (en) PROCESS FOR CLEANING PROTEINS
BRPI1011061A2 (pt) automacao de abatimento
PL2522724T3 (pl) Sposób modyfikowania polipetydów do oczyszczania multimerów polipeptydowych
BRPI1013538A2 (pt) azetidinil diamidas como inibidores de monoacilglicerol lipase
IL219715A (en) Sewage treatment apparatus
DK2477592T3 (da) Rollatorkørestol
EP2509639A4 (en) DISINFECTION SYSTEM FOR HARD SURFACES
BRPI1008300A2 (pt) processo de purificação de daptomicina
EP2391391A4 (en) STERILIZATION PROCESS
BRPI1011933A2 (pt) composição de purificação de gás ácido
SMT201500142B (it) Procedimento per la purificazione di proteine
EP2412714A4 (en) PROCESS FOR THE INDUSTRIAL CLEANING OF BIOLOGICALLY ACTIVE PHYTOTOXINS
EP2499255A4 (en) EFFICIENT PRODUCTION OF PEPTIDES
PT2504298T (pt) Preparação e purificação de iodoxanol
BRPI0924579A2 (pt) método de cultura de organismos fotossintéticos
EP2405946A4 (en) STERILIZATION PROCESS
BRPI0915394A2 (pt) purificação de citoquinas modificadas
BRPI0922716A2 (pt) purificação de polipeptídeo
BR112012004676A2 (pt) método de tratar infecções orotomixovirais.
EP2519537A4 (en) CLEANING PROTEINS
EP2269969A4 (en) PROCESS FOR CLEANING TETRAFLUOROETHYLENE

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF